These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9065958)

  • 21. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine, verapamil and diltiazem.
    García Pérez B; Ayala I; Castells MT; Madrid JF; Ortega MR; Ortega JV; Ballesta J; Fernández Pardo J; Valdés M
    Histol Histopathol; 2003 Oct; 18(4):1027-33. PubMed ID: 12973671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease.
    Matsuda Y; Akita H; Terashima M; Shiga N; Kanazawa K; Yokoyama M
    Am Heart J; 2000 Nov; 140(5):753-9. PubMed ID: 11054621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol attenuates the progression of alcohol fatty liver disease in rats.
    Liu J; Takase I; Hakucho A; Okamura N; Fujimiya T
    Alcohol Clin Exp Res; 2012 Sep; 36(9):1587-99. PubMed ID: 22413959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
    Watanabe K; Takahashi T; Nakazawa M; Wahed MI; Fuse K; Tanabe N; Kodama M; Aizawa Y; Ashino H; Tazawa S
    J Nucl Med; 2002 Apr; 43(4):531-5. PubMed ID: 11937598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG; Baxter GA; Young PH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carvedilol (Kredex) reduces infarct size in a canine model of acute myocardial infarction.
    Hamburger SA; Barone FC; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1991; 43(3):113-20. PubMed ID: 1685569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
    Deepa PR; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats.
    Adan Y; Shibata K; Sato M; Ikeda I; Imaizumi K
    Biosci Biotechnol Biochem; 1999 Jan; 63(1):111-9. PubMed ID: 10052130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
    Yasuda G; Yatsu K; Yamamoto Y; Hirawa N
    Kidney Blood Press Res; 2012; 36(1):131-8. PubMed ID: 23095799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of carvedilol on the serum lipid profile.
    Sharp RP; Sirajuddin R; Sharief IM
    Ann Pharmacother; 2008 Apr; 42(4):564-71. PubMed ID: 18364407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.
    Overturf ML; Smith SA
    Artery; 1986; 13(5):267-82. PubMed ID: 3527114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.